SG Americas Securities LLC trimmed its holdings in shares of Cabot Corporation (NYSE:CBT – Free Report) by 61.6% during the 3rd quarter, Holdings Channel reports. The fund owned 10,085 shares of the specialty chemicals company’s stock after selling 16,188 shares during the period. SG Americas Securities LLC’s holdings in Cabot were worth $767,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. Elevation Point Wealth Partners LLC purchased a new stake in shares of Cabot in the 2nd quarter worth approximately $28,000. Parkside Financial Bank & Trust raised its stake in Cabot by 95.5% in the second quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock worth $29,000 after buying an additional 189 shares in the last quarter. Geneos Wealth Management Inc. lifted its holdings in Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 364 shares during the period. UMB Bank n.a. boosted its position in Cabot by 52.4% during the 2nd quarter. UMB Bank n.a. now owns 730 shares of the specialty chemicals company’s stock valued at $55,000 after acquiring an additional 251 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its holdings in shares of Cabot by 344.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 813 shares of the specialty chemicals company’s stock valued at $61,000 after acquiring an additional 630 shares during the period. Institutional investors own 93.18% of the company’s stock.
Analysts Set New Price Targets
CBT has been the subject of a number of analyst reports. Zacks Research cut Cabot from a “hold” rating to a “strong sell” rating in a research note on Friday, November 7th. Jefferies Financial Group reiterated a “buy” rating and issued a $81.00 target price on shares of Cabot in a report on Thursday, January 8th. UBS Group raised their price target on shares of Cabot from $65.00 to $74.00 and gave the company a “neutral” rating in a report on Monday, January 12th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cabot in a research report on Monday, December 29th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a research report on Friday, November 28th. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Cabot presently has a consensus rating of “Hold” and an average price target of $72.25.
Cabot Price Performance
Shares of NYSE CBT opened at $69.36 on Wednesday. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $92.89. The company has a market cap of $3.67 billion, a PE ratio of 11.54, a P/E/G ratio of 3.71 and a beta of 0.89. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.08 and a current ratio of 1.61. The business has a 50-day simple moving average of $66.30 and a two-hundred day simple moving average of $71.97.
Cabot (NYSE:CBT – Get Free Report) last announced its quarterly earnings data on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing the consensus estimate of $1.72 by ($0.02). The company had revenue of $899.00 million during the quarter, compared to analysts’ expectations of $967.02 million. Cabot had a net margin of 8.91% and a return on equity of 24.55%. The business’s revenue for the quarter was down 10.2% compared to the same quarter last year. During the same period in the previous year, the business earned $1.80 earnings per share. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. As a group, equities analysts expect that Cabot Corporation will post 7.57 EPS for the current fiscal year.
Cabot Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, December 12th. Stockholders of record on Friday, November 28th were paid a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a dividend yield of 2.6%. The ex-dividend date was Friday, November 28th. Cabot’s payout ratio is presently 29.95%.
About Cabot
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Featured Stories
- Five stocks we like better than Cabot
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
